Clinical trial
Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis
NCT00417872 · Romark Laboratories L.C., Industry · Completed
Key facts
| NCT number | NCT00417872 |
|---|---|
| Title | Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis |
| Official title | Multicenter, Double Blind, Metronidazole Controlled, Dose Range Finding Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis |
| Lead sponsor | Romark Laboratories L.C., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Clostridium Difficile |
| Intervention type | Drug |
| Interventions | Nitazoxanide, Metronidazole |
| Enrollment | 114 |
| Start date | Jan 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Jan 4, 2007 |
| Last update posted | Jan 4, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: